We are live on ! Find out more
PSTV

Plus Therapeutics
PSTV

Delisted

PSTV was delisted on the 31st of July, 2026.

Back to rankings

3 hedge funds and large institutions have $19.3M invested in Plus Therapeutics in 2015 Q1 according to their latest regulatory filings, with funds opening new positions, increasing their positions, reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

158% more capital invested

Capital invested by funds: $7.5M → $19.3M (+$11.8M)

25% less funds holding

Funds holding: 4 → 3 (-1)

57% less call options, than puts

Call options by funds: $16K | Put options by funds: $37K

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 1

Holders
3
Holders Change
-1
Holders Change %
-25%
% of All Funds
0.08%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
1
Calls
$16K
Puts
$37K
Net Calls
-$21K
Net Calls Change
-$20K

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
SM
Sabby Management
Florida
-$2.19M
2
GCM
Goldman Capital Management
New York
-$204K
3
D.E. Shaw & Co
D.E. Shaw & Co
New York
-$87K
4
VKH
Virtu KCG Holdings
New York
-$73K
5
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$61K
Name Holding Trade Value Shares
Change 		Change in
Stake
Susquehanna International Group
76
Susquehanna International Group
Pennsylvania
– -$61K – –
Two Sigma Advisers
77
Two Sigma Advisers
New York
– -$5K – –
VKH
78
Virtu KCG Holdings
New York
– -$73K – –
1 2 3
4

PSTV Hedge Fund Activity: Q1 2015 in Review

3 of the 3,754 institutional investors tracked by Wall St. Rank reported a position in Plus Therapeutics (PSTV) for Q1 2015, worth a combined $19.3M — up 158% from $7.5M a quarter earlier.

Sellers outnumbered buyers: 1 fund closed out of PSTV and 0 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 0 added.

The largest seller was Sabby Management, exiting entirely with an estimated $2.19M sold.

  • 3 institutional investors held Plus Therapeutics (PSTV) as of Q1 2015, down from 4 in Q4 2014.
  • Funds reported $19.3M of Plus Therapeutics stock for Q1 2015, up 158% quarter-over-quarter.
  • 0 funds opened new Plus Therapeutics positions in Q1 2015 and 1 closed out, a net change of -1 holder.
  • The largest Plus Therapeutics seller in Q1 2015 was Sabby Management, an estimated $2.19M sold.

Based on aggregated 13F filings for Q1 2015.